AU2001274649A1 - Topical preparation of alprostadil for the treatment of erectile dysfunction - Google Patents
Topical preparation of alprostadil for the treatment of erectile dysfunctionInfo
- Publication number
- AU2001274649A1 AU2001274649A1 AU2001274649A AU7464901A AU2001274649A1 AU 2001274649 A1 AU2001274649 A1 AU 2001274649A1 AU 2001274649 A AU2001274649 A AU 2001274649A AU 7464901 A AU7464901 A AU 7464901A AU 2001274649 A1 AU2001274649 A1 AU 2001274649A1
- Authority
- AU
- Australia
- Prior art keywords
- alprostadil
- treatment
- erectile dysfunction
- topical preparation
- topical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 title 1
- 208000010228 Erectile Dysfunction Diseases 0.000 title 1
- 229960000711 alprostadil Drugs 0.000 title 1
- 201000001881 impotence Diseases 0.000 title 1
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2000-0034767A KR100402334B1 (en) | 2000-06-23 | 2000-06-23 | Alprostadil-containing composition for external application |
| KR0034767 | 2000-06-23 | ||
| PCT/KR2001/001050 WO2001097777A1 (en) | 2000-06-23 | 2001-06-20 | Topical preparation of alprostadil for the treatment of erectile dysfunction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001274649A1 true AU2001274649A1 (en) | 2002-01-02 |
Family
ID=19673440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001274649A Abandoned AU2001274649A1 (en) | 2000-06-23 | 2001-06-20 | Topical preparation of alprostadil for the treatment of erectile dysfunction |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US6500440B1 (en) |
| KR (1) | KR100402334B1 (en) |
| AU (1) | AU2001274649A1 (en) |
| WO (1) | WO2001097777A1 (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100402334B1 (en) * | 2000-06-23 | 2003-10-22 | 환인제약 주식회사 | Alprostadil-containing composition for external application |
| KR100373540B1 (en) * | 2000-09-20 | 2003-02-25 | 최한곤 | Composite of transurethral suppository containing prostaglandin E1 |
| ITMI20012139A1 (en) * | 2001-10-16 | 2003-04-16 | B & T S R L | NATURAL EMULSIFIER FOR COSMETICS |
| KR100810404B1 (en) * | 2001-12-18 | 2008-03-04 | 환인제약 주식회사 | External preparation composition containing alprostadyl alkyl ester |
| US6841574B2 (en) * | 2003-01-03 | 2005-01-11 | Nexmed Holdings, Inc. | Topical stabilized prostaglandin E compound dosage forms |
| AU2004224459A1 (en) * | 2003-03-21 | 2004-10-07 | Nexmed (Holdings), Inc. | Angiogenesis promotion by prostaglandin compositions and methods |
| KR20110007088A (en) * | 2008-01-25 | 2011-01-21 | 비 앤드 티 에스.알.엘. | Use of Transesterified Olive Oil in Cosmetics |
| US20110280969A1 (en) | 2010-05-12 | 2011-11-17 | Waxelene, Inc. | Petroleum-free compositions for skin care and other applications, and methods of making same |
| DE102010046680A1 (en) * | 2010-09-16 | 2012-03-22 | Clariant International Limited | Use of N-substituted 2-pyrrolidone-4-carboxylic esters as solvents |
| CN102692462B (en) * | 2012-06-03 | 2014-01-08 | 浙江大学 | A method for determining the content of 8 active ingredients in Danhong injection |
| US20140061541A1 (en) * | 2012-08-31 | 2014-03-06 | Abjp, Llc | Razor blade preservation system and method |
| JP7032037B2 (en) * | 2013-02-27 | 2022-03-08 | ロバート バット ローリー | Transdermal preparation |
| CN104215711A (en) * | 2014-09-15 | 2014-12-17 | 湖北中烟工业有限责任公司 | Fingerprint determination method of active ingredients in cocoa powder |
| WO2017168174A1 (en) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
| JP2022509359A (en) * | 2018-10-26 | 2022-01-20 | ガラニン、アイバン | Topical compositions and methods for promoting optimal dermal white adipose tissue formation in vivo |
| KR102616353B1 (en) | 2020-07-10 | 2023-12-26 | 엘지전자 주식회사 | Deposition apparatus |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0737389B2 (en) * | 1989-08-29 | 1995-04-26 | 久光製薬株式会社 | Ointment containing prostaglandin E1 |
| RO105296B1 (en) * | 1989-12-04 | 1994-07-20 | Viorica Hadisan | Cosmetics product for babies |
| WO1993008804A1 (en) * | 1991-11-08 | 1993-05-13 | Kyoto Pharmaceutical Industries, Ltd. | Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration |
| US5773457A (en) * | 1995-02-15 | 1998-06-30 | Cesar Roberto Dias Nahoum | Compositions |
| US5380760A (en) | 1993-11-19 | 1995-01-10 | Minnesota Mining And Manufacturing Company | Transdermal prostaglandin composition |
| ES2141950T3 (en) | 1994-08-05 | 2000-04-01 | Inpharma Sa | COMPOSITIONS CONTAINING TROXERUTINE COMPLEXED WITH PHOSFATIDYLCHOLINE FOR THE TOPICAL TREATMENT OF ERECTILE IMPOTENCE. |
| US5741511A (en) | 1995-04-12 | 1998-04-21 | Sam Yang Co., Ltd. | Transdermal drug delivery device for treating erectile dysfunction |
| US6036977A (en) | 1995-09-29 | 2000-03-14 | L.A.M. Pharmaceutical Corp. | Drug preparations for treating sexual dysfunction |
| US6046244A (en) * | 1997-11-05 | 2000-04-04 | Nexmed Holdings, Inc. | Topical compositions for prostaglandin E1 delivery |
| US6031002A (en) | 1998-05-01 | 2000-02-29 | Michael Ebert | Method for enhancing female sexual response and a composition therefor |
| US6046240A (en) | 1998-05-01 | 2000-04-04 | Harvard Scientific Corporation | Methods for treating female sexual dysfunction |
| US5942545A (en) * | 1998-06-15 | 1999-08-24 | Macrochem Corporation | Composition and method for treating penile erectile dysfunction |
| CA2335736A1 (en) | 1998-06-25 | 1999-12-29 | Lavipharm Laboratories, Inc. | A device and method for the treatment of erectile dysfunction |
| KR100453803B1 (en) * | 1999-07-29 | 2004-10-20 | 환인제약 주식회사 | Alprostadil-containing compositions for external use |
| KR100402334B1 (en) * | 2000-06-23 | 2003-10-22 | 환인제약 주식회사 | Alprostadil-containing composition for external application |
-
2000
- 2000-06-23 KR KR10-2000-0034767A patent/KR100402334B1/en not_active Expired - Fee Related
- 2000-08-29 US US09/649,059 patent/US6500440B1/en not_active Expired - Fee Related
-
2001
- 2001-06-20 WO PCT/KR2001/001050 patent/WO2001097777A1/en not_active Ceased
- 2001-06-20 AU AU2001274649A patent/AU2001274649A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US6500440B1 (en) | 2002-12-31 |
| KR100402334B1 (en) | 2003-10-22 |
| KR20020000316A (en) | 2002-01-05 |
| WO2001097777A1 (en) | 2001-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001252135A1 (en) | Therapeutic agents | |
| AU2002223827A1 (en) | Well treatment | |
| AU4583899A (en) | Nasal administration of sildenafil for the treatment of erectile dysfunction | |
| AU2001245965A1 (en) | Large body stretcher | |
| AU2001274649A1 (en) | Topical preparation of alprostadil for the treatment of erectile dysfunction | |
| AU9153601A (en) | Portable sauna | |
| IL151890A0 (en) | Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain | |
| AU2001250821A1 (en) | Methods and compositions for the treatment and prevention of erectile dysfunction | |
| AU2001265253A1 (en) | Treatment of hiv using hyperthermia | |
| AU2001260834A1 (en) | The treatment of herpes | |
| IL151891A0 (en) | Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain | |
| IL151765A0 (en) | Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain | |
| AU2001284763A1 (en) | Preparation of risperidone | |
| AU2001278680A1 (en) | Erectile dysfunction remedies containing prostaglandin derivatives as the activeingredient | |
| AU7652400A (en) | Novel combination for the treatment of sexual dysfunction | |
| AU2001284125A1 (en) | Medicine for fighting against sexual dysfunction | |
| AU5509099A (en) | Pyridinones for the treatment of sexual dysfunction | |
| AU2641199A (en) | Remedies for erectile dysfunction | |
| AU2001273903A1 (en) | Therapeutic agents | |
| PL362980A1 (en) | Treatment of sexual dysfunction | |
| AU2001237379A1 (en) | Use of benzothieno-2,3-D-pyrimidines with PDE V inhibitory effect for the treatment of erectile dysfunction | |
| AU2001294179A1 (en) | Massaging device | |
| AU2001275696A1 (en) | Therapeutic agent | |
| AU6733500A (en) | Agents for ameliorating erectile dysfunction | |
| AU2001285959A1 (en) | Helium-oxygen mixture with therapeutic application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase | ||
| TH | Corrigenda |
Free format text: IN VOL 16, NO 12, PAGE(S) 2688-2711 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 50578/00, 50580/00, 55758/00, 57119/00, 58642/00, 70409/00, 11771/01, 19844/01, 22347/01, 24081/01, 56837/01, 58896/01, 58898/01, 61914/01, 62021/01, 62771/01, 62783/01, 62803/01, 62804/01, 64355/01, 64359/01, 64360/01, 64361/01, 64364/01, 64366/01, 64369/01, 65685/01, 66189/01, 66319/01, 69200/01, 70677/01, 72586/01, 74264/01, 74277/01, 74317/01, 74344/01, 74400/01, 74649/01, 84539/01, 85731/01, 13599/02 |